FI974444L - N-hydroksiureayhdisteitä anti-inflammatorisina aineina - Google Patents

N-hydroksiureayhdisteitä anti-inflammatorisina aineina Download PDF

Info

Publication number
FI974444L
FI974444L FI974444A FI974444A FI974444L FI 974444 L FI974444 L FI 974444L FI 974444 A FI974444 A FI 974444A FI 974444 A FI974444 A FI 974444A FI 974444 L FI974444 L FI 974444L
Authority
FI
Finland
Prior art keywords
inflammatory agents
hydroxyurea compounds
hydroxyurea
compounds
inflammatory
Prior art date
Application number
FI974444A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974444A7 (fi
FI974444A0 (fi
Inventor
Akemi Ando
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974444A0 publication Critical patent/FI974444A0/fi
Publication of FI974444A7 publication Critical patent/FI974444A7/fi
Publication of FI974444L publication Critical patent/FI974444L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI974444A 1994-05-19 1995-06-07 N-hydroksiureayhdisteitä anti-inflammatorisina aineina FI974444L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12810594A JP3179286B2 (ja) 1994-05-19 1994-05-19 Ｎ−ヒドロキシ尿素系抗炎症剤
PCT/JP1995/001127 WO1996040659A1 (en) 1994-05-19 1995-06-07 N-hydroxyureas as antiinflammatory agents
CA002223023A CA2223023C (en) 1994-05-19 1995-06-07 N-hydroxyureas as antiinflammatory agents

Publications (3)

Publication Number Publication Date
FI974444A0 FI974444A0 (fi) 1997-12-05
FI974444A7 FI974444A7 (fi) 1998-02-04
FI974444L true FI974444L (fi) 1998-02-04

Family

ID=27170556

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974444A FI974444L (fi) 1994-05-19 1995-06-07 N-hydroksiureayhdisteitä anti-inflammatorisina aineina

Country Status (19)

Country Link
US (1) US5814648A (cs)
EP (1) EP0832078B1 (cs)
JP (2) JP3179286B2 (cs)
AT (1) ATE185803T1 (cs)
AU (1) AU705505B2 (cs)
BR (1) BR9502072A (cs)
CA (1) CA2223023C (cs)
CZ (1) CZ286331B6 (cs)
DE (1) DE69512940T2 (cs)
DK (1) DK0832078T3 (cs)
ES (1) ES2138211T3 (cs)
FI (1) FI974444L (cs)
GR (1) GR3032301T3 (cs)
HU (1) HUT77950A (cs)
IL (1) IL113706A (cs)
NO (1) NO310288B1 (cs)
NZ (1) NZ287551A (cs)
PL (1) PL179853B1 (cs)
WO (1) WO1996040659A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548419A1 (de) 1995-12-22 1997-06-26 Bayer Ag Substituierte Thiazoline
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2602336A1 (en) * 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2021214048A1 (en) * 2020-04-20 2021-10-28 Johann Wolfgang Goethe-Universität Frankfurt am Main Dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0540673T3 (da) * 1990-07-25 1997-03-24 Abbott Lab Acetylen-derivater med lipoxygenaseinhiberende virkning
JP2528741B2 (ja) * 1991-01-09 1996-08-28 ファイザー製薬株式会社 オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物
JPH07100687B2 (ja) * 1991-06-13 1995-11-01 ファイザー製薬株式会社 新規なｎ−ヒドロキシ尿素化合物および組成物
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
DE69411003T2 (de) * 1993-04-07 1998-10-08 Pfizer Inc., New York, N.Y. Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren

Also Published As

Publication number Publication date
BR9502072A (pt) 1996-04-09
ATE185803T1 (de) 1999-11-15
JPH10506649A (ja) 1998-06-30
FI974444A7 (fi) 1998-02-04
DE69512940D1 (de) 1999-11-25
CA2223023A1 (en) 1996-12-19
EP0832078A1 (en) 1998-04-01
FI974444A0 (fi) 1997-12-05
AU2629495A (en) 1996-12-30
US5814648A (en) 1998-09-29
WO1996040659A1 (en) 1996-12-19
HUT77950A (hu) 1998-12-28
ES2138211T3 (es) 2000-01-01
JPH07309849A (ja) 1995-11-28
EP0832078B1 (en) 1999-10-20
NO310288B1 (no) 2001-06-18
IL113706A (en) 1999-08-17
CA2223023C (en) 2001-07-17
PL179853B1 (pl) 2000-11-30
NO975726L (no) 1998-02-03
AU705505B2 (en) 1999-05-27
PL324012A1 (en) 1998-04-27
DK0832078T3 (da) 2000-04-25
MX9709986A (es) 1998-03-29
NO975726D0 (no) 1997-12-05
NZ287551A (en) 1999-02-25
GR3032301T3 (en) 2000-04-27
CZ286331B6 (cs) 2000-03-15
CZ382497A3 (cs) 1999-03-17
IL113706A0 (en) 1995-08-31
DE69512940T2 (de) 2000-02-17
JP3179286B2 (ja) 2001-06-25

Similar Documents

Publication Publication Date Title
DK0777671T3 (da) Spiro-azabicykliske forbindelser
PT966430E (pt) Compostos anti-inflamatorios
FI971260A7 (fi) 1-asyyli-4-alifatyyliaminopiperidiiniyhdisteet
FI945557A7 (fi) Isoksatsoliiniyhdisteet tulehduksenvastaisina aineina
BR9509760A (pt) Composto
FI954327L (fi) Atsasykloheksapeptidiyhdisteitä
FI970995L (fi) Farmaseuttisia yhdisteitä
FI971018L (fi) Farmaseuttisia yhdisteitä
FI970907L (fi) Pyridatsinokinoliiniyhdisteitä
FI962749L (fi) Uusia heterosyklisiä yhdisteitä
NL300435I1 (nl) Enterokinetische benzamideverbinding
FI954243A7 (fi) Farmaseuttiset yhdisteet
FI972683A7 (fi) Kemiallisia yhdisteitä
FI954016A7 (fi) Uudet yhdisteet
FI971674A7 (fi) Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyt tökelpoisia tulehduksenvastaisina aineina
DK72693D0 (da) Compounds
FI950403L (fi) Neurosuojaavia yhdisteitä
FI974444A7 (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
FI970279L (fi) Orgaanisia yhdisteitä
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DK124393D0 (da) Compounds
BR9509740A (pt) Compostos 18-nor-vitamina d
FI971971A7 (fi) Pyridatsinokinoliiniyhdisteitä
FI954017L (fi) Uudet yhdisteet
FI955896L (fi) Uudet aktiiviset yhdisteet

Legal Events

Date Code Title Description
MA Patent expired